2.31%C 7.40 5.37%QQQQ 27.81 2.83%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
WASHINGTON - The chairman and chief executive of United Therapeutics Corp. exercised options for 12,200 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing.
| UTHR | 51.34 |  -1.16 |
In a Form 4 filed Friday with the SEC, Martine Rothblatt reported she exercised the options Wednesday and Thursday for $27.50 and $43.60 apiece and then sold all 12,200 shares on the same days for $89.19 to $90 apiece.
The stock sale was conducted under a prearranged 10b5-1 trading plan which allows company insiders to set up a program in advance for such transactions and proceed even if they come into possession of material nonpublic information.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
United Therapeutics, which is a biotechnology company, is based in Silver Spring, Md.
U.S. stocks were mixed on Thursday after retailers reported mostly disappointing sales while other big-name companies announced layoffs and Europ...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
The markets have spoken: risk aversion is still the name of the game and that was obvious since the beginning of the week.
|
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Building your business and corporate credit for your small business.
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
